EPATOCARCINOMA DA EPATITE CRONICA DA VIRUS B. ENTECAVIR vs TENOFOVIR. UNA COORTE NAZIONALE DALLA COREA. “JAMA ONCOLOGY” (FREE)
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study Jonggi Choi, M et al. IMPORTANCE Entecavir and tenofovir disoproxil fumarate have comparable efficacy in achieving surrogate end points, including virologic response, and are equally recommended as first-line treatments for patients with chronic hepatitis B…

